Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL

被引：5
|
作者：
Torekov, Signe Sorensen [1 ]
机构：
[1] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Panum Room 12-2-10,Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark
来源：
CARDIOVASCULAR RESEARCH | 2018年 / 114卷 / 10期
关键词：
GLP-1; CARDIOPROTECTION; LIXISENATIDE; LIRAGLUTIDE; OUTCOMES; OBESITY;
D O I：
10.1093/cvr/cvy124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E70 / E71
页数：2
相关论文
共 50 条
  • [1] Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular disease
    Tirandi, Amedeo
    Montecucco, Fabrizio
    Carbone, Federico
    Liberale, Luca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (02):
  • [2] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [3] Potential Cardiovascular Effects of the Glucagon-like Peptide-1 Receptor Agonists
    Chilton, Robert J.
    JOURNAL OF DIABETES & METABOLISM, 2015, 6 (01)
  • [4] Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus A Role in Cardiovascular Disease
    Smilowitz, Nathaniel R.
    Donnino, Robert
    Schwartzbard, Arthur
    CIRCULATION, 2014, 129 (22) : 2305 - 2312
  • [5] The potential of glucagon-like peptide-1 receptor agonists in heart failure
    Kreiner, Frederik Flindt
    Hovingh, G. Kees Kornelis
    von Scholten, Bernt Johan
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [6] Glucagon-like peptide-1 receptor agonists and safety in the preconception period
    Minis, Evelyn
    Stanford, Fatima Cody
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (06) : 273 - 279
  • [7] NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
    Shamhalova, Minara S.
    Sklyanik, Igor A.
    Shestakova, Marina V.
    DIABETES MELLITUS, 2020, 23 (01): : 56 - 64
  • [8] Renal protection with glucagon-like peptide-1 receptor agonists
    Vitale, Martina
    Haxhi, Jonida
    Cirrito, Tiziana
    Pugliese, Giuseppe
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 91 - 101
  • [9] The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
    Fang, Haowen
    Niu, Bing
    Chen, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2921 - 2943
  • [10] Glucagon-like peptide-1 receptor agonists and kidney outcomes
    MacIsaac, Richard J.
    Trevella, Philippa
    Ekinci, Elif I.
    JOURNAL OF DIABETES, 2024, 16 (10)
12345